Step 1 topics → Musculoskeletal, Skin, and Connective Tissue → Paget Disease of Bone

Paget Disease of Bone

USMLE Step 1 trap: Confuses Paget disease lab hallmark as elevated calcium rather than elevated alkaline phosphatase. Paget disease characteristically shows markedly elevated alkaline phosphatase with normal serum calcium and phosphate in the absence of immobilization.

Paget disease of bone (osteitis deformans) is a focal disorder of bone remodeling where overactive osteoclasts drive disorganized bone turnover, ultimately producing structurally weak, expanded bone with a characteristic mosaic pattern on histology. USMLE Step 1 tests this disease from multiple angles: recognizing the classic presentation (older patient, skull enlargement, increased hat size, bone pain), interpreting labs correctly, understanding the three sequential phases, and knowing the serious complications. It shows up both as straightforward recall and as clinical vignettes where you need to distinguish Paget from other metabolic bone diseases.

The trickiest part is the lab profile. Students frequently confuse this with hypercalcemia disorders like hyperparathyroidism or malignancy, but Paget's hallmark is a markedly elevated alkaline phosphatase with normal calcium and phosphate. The exam loves to test whether you understand why: bone turnover is dramatically increased, but serum calcium stays normal because the process is coupled (resorption and formation are both up). Calcium only rises if the patient is immobilized.

The other high-yield trap is complications. USMLE Step 1 will give you a patient with known Paget disease who develops new bone pain or a sudden rise in ALP after a stable period — this should immediately trigger osteosarcoma transformation on your differential. High-output heart failure from arteriovenous shunting in hypervascular bone is another systemic complication that trips students who don't connect bone hypervascularity to cardiovascular effects. Know the full complication list and know that bisphosphonates, not calcitonin, are first-line.

From real student decks
70%have cards covering this topic
65%have mature cards

Common misconceptions

Common mistake
Wrong: Paget disease causes elevated serum calcium as its hallmark lab finding.
Right: Paget disease characteristically shows markedly elevated alkaline phosphatase with normal serum calcium and phosphate in the absence of immobilization.
Elevated calcium is the hallmark of hyperparathyroidism and malignancy — not Paget disease. In Paget, osteoclast activity is dramatically increased but osteoblasts are working hard to compensate, so bone formation and resorption are both elevated and calcium stays in normal range. Alkaline phosphatase, a marker of osteoblast activity, skyrockets instead. The only time Paget causes hypercalcemia is during immobilization, when formation slows but resorption continues.
Common mistake
Gap: Missing that osteosarcoma is a serious oncologic complication of long-standing Paget disease
Paget disease carries a risk of transformation to osteosarcoma, which should be suspected when a patient with known Paget develops new bone pain or a rising ALP after a period of stability.
Long-standing Paget disease creates a chaotic bone microenvironment with high cell turnover, and in roughly 1% of patients this leads to malignant transformation — most commonly osteosarcoma. The red flag on a vignette is a patient with previously stable Paget who suddenly develops worsening bone pain or a sharp unexplained rise in ALP. Don't chalk up new pain to disease progression without considering this complication; the prognosis of Paget-associated osteosarcoma is very poor.
Common mistake
Wrong: Paget disease begins with a sclerotic phase of increased bone formation.
Right: Paget disease begins with an osteolytic phase of excessive osteoclast activity, followed by a mixed phase, and then a sclerotic (burned-out) phase of disorganized woven bone.
It's intuitive to think of Paget as primarily a bone-forming disease because the bones look thick and sclerotic on imaging — but the disease actually starts with explosive osteoclast activity (the lytic phase). The osteoblasts then frantically try to fill in the damage, producing disorganized woven bone in the mixed phase. The final sclerotic or 'burned-out' phase is the result of that chaotic repair, not the initiating event. Getting the sequence right matters because early Paget on imaging looks lytic, not dense.
Common mistake
Wrong: Calcitonin is the first-line treatment for Paget disease.
Right: Bisphosphonates (especially zoledronic acid) are first-line for Paget disease; calcitonin is a second-line option.
Calcitonin used to be the go-to treatment before bisphosphonates were established, so it's still commonly listed as an option — but it is no longer first-line. Bisphosphonates, particularly zoledronic acid (a single IV infusion), suppress osteoclast activity far more effectively and durably. Calcitonin is now reserved for patients who cannot tolerate bisphosphonates. On USMLE Step 1, if the question asks what to treat Paget with, bisphosphonates are the answer.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the three sequential phases of Paget disease — osteolytic (osteoclast-driven), mixed, and sclerotic (burned-out) — and identify the mosaic pattern of woven bone on histology as the defining microscopic hallmark.
  2. Interpret the Paget lab profile: markedly elevated alkaline phosphatase with normal serum calcium and phosphate, and distinguish this pattern from hyperparathyroidism, osteomalacia, and bone metastases.
  3. Recognize the classic clinical presentation: older adult with bone pain, skull enlargement (increasing hat size), frontal bossing, hearing loss (CN VIII compression), and incidental x-ray findings of mixed lytic/sclerotic bone lesions.
  4. Identify the major complications of Paget disease: osteosarcoma transformation (suspect with new pain or rising ALP in a stable patient), high-output heart failure from hypervascular bone, pathologic fractures, and nerve compression syndromes.
  5. Select the correct first-line treatment: bisphosphonates (especially zoledronic acid) are preferred over calcitonin, which is reserved as a second-line option.

Can you avoid these mistakes?

A 68-year-old man presents with headaches and has needed larger hat sizes over the past decade. Labs show ALP of 480 U/L (markedly elevated), calcium 9.4 mg/dL (normal), and phosphate 3.2 mg/dL (normal). What is the diagnosis, and why isn't calcium elevated?
A biopsy of pagetic bone shows irregular cement lines forming a jigsaw-puzzle appearance. What is this called, which phase of disease does it represent, and what two cell types drove the earlier phases?
A patient with known Paget disease of the femur has been stable for years, but now reports severe new thigh pain and repeat labs show ALP has doubled from his previous baseline. What serious complication must you consider, and what is the prognosis?
You are choosing between zoledronic acid and calcitonin to treat a newly diagnosed patient with symptomatic Paget disease. Which do you choose and why? Under what circumstance would you use the other agent?

Related topics

Bone Cells and Matrix Endochondral vs Membranous Ossification Fracture Healing Stages Compartment Syndrome

See how your Anki deck covers this topic.

Upload your deck for a free audit →